<1,18> number sbc determin section interv
<1,19> minimum high power field hpf count biopsi averag number sbc hpf determin
<1,20> differ number sbc med evalu analysi varianc anova contrast protect ttest compar treatment
<1,21> med aha pha treatment reduc averag med compar untreat glycol acid gluconolacton notsignific compar untreat control
<1,25> sbc increas averag number sbc high power field hpf glycol acid treat site compar untreat
<1,26> test site treat gluconolacton untreat
